Author: seaprwire

Seoul Bio Hub and Celltrion Launch Strategic Gateway ‘Global Open Innovation’ to Help U.S. Bio Startups Dominate the Asian Market Two U.S.-Based Biotech and Medical Device Startups to Be Selected Based on Technology Alignment with Celltrion’s Expertise in Antibodies, Peptides, and Drug Formulation Seoul, Korea – September 16, 2025 – (SeaPRwire) – Seoul’s bio startup hub ‘Seoul Bio Hub’ and global pharmaceutical leader ‘Celltrion’ have joined forces to launch the ‘2025 Seoul Bio Hub-Celltrion Global Open Innovation (GOI)’ program. This program goes beyond a simple competition, serving as a platform designed to help U.S. startups successfully establish themselves in the Asian market. This GOI targets U.S.-based bio and medical startups, with companies established within the past 7 years eligible to apply. The recruitment areas encompass all technologies suitable for collaboration with Celltrion, including antibodies, peptides, small molecules, formulations, and cell and gene therapies. The application deadline is September 30, 2025. The selection process will proceed in the following order: Primary document evaluation Technology review Secondary presentation evaluation. The two finally selected companies will receive customized follow-up support and gain opportunities to expand into global markets through collaboration with Celltrion, leveraging South Korea’s innovative ecosystem and global capabilities. A Seoul Bio Hub representative stated, “This program will serve as a bridgehead that goes beyond simple space support, enabling U.S. startups to rapidly grow in the Asian market by leveraging Seoul’s excellent clinical infrastructure and research environment.” A Celltrion representative announced, “Based on Celltrion’s capabilities and know-how accumulated across the entire pharmaceutical industry process including R&D, production, and sales, we will support promising U.S. startups to successfully enter the Asian market and create synergy with our company.” South Korea has established itself as a bio hub leading the global market with clear numerical evidence. According to global consulting firm Intralink, South Korea’s biopharmaceutical market is valued at approximately $22 billion, ranking 13th globally. Additionally, market research firm Grand View Research forecasts that South Korea’s biotechnology market will grow to $81.6 billion (approximately 110 trillion KRW) by 2030, representing an annual average growth rate of 18.3%. Private investment is also active. From 2020 to 2022, R&D and facility investments recorded an annual average growth rate of 21.6%. This demonstrates that South Korea is not merely a potential market, but a rapidly growing innovation ecosystem. According to ClinicalTrials.gov, the global clinical trial database, Seoul has consistently maintained a top position among major global cities in the number of new clinical trials over the past decade. South Korea’s Ministry of Health and Welfare has set ‘Achieving Global 3rd Place in Clinical Trials’ as a policy objective through the ‘3rd Five-Year Plan for the Pharmaceutical and Bio Industry (2023-2027)’. Furthermore, in 2025, it raised a total of over 386.6 billion KRW through the ‘Bio Health Mega Fund’ and is actively supporting innovative companies’ clinical trials and commercialization through the national integrated bio big data construction project and AI, bio health regulatory regulatory sandboxes. Seoul Bio Hub is a bio startup support organization established by Seoul City in 2017. It provides 251 pieces of shared laboratory equipment and affordable tenant space at 10% of the cost compared to major areas in Seoul. As of May 2025, it has supported 322 startups and attracted a total of 576 billion KRW in follow-up investment, proving its potential for success. Celltrion is South Korea’s global comprehensive biotechnology company that developed the world’s first antibody biosimilar ‘Remsima’. The company performs the entire process from research and development to approval, production, and sales, supplying high-quality biopharmaceuticals to over 100 countries worldwide. Based on world-class research and production infrastructure, it contributes to expanding global access to pharmaceuticals and continues to support and collaborate with promising startups through active open innovation strategies. For detailed information regarding program applications and inquiries, please access LinkedIn, search for ‘Seoul Bio Hub’, and check the 「2025 Seoul Bio Hub-Celltrion Global Open Innovation」 recruitment announcement posted on the official company page. About Seoul Bio Hub https://www.seoulbiohub.kr/front/user/engmain.do Establishment Date: October 30, 2017 Operating Entity: Established by Seoul City / Joint operation by KIST and Korea University Location: 117-3 Hoegi-ro, Dongdaemun-gu, Seoul, Republic of Korea Purpose: Growth and commercialization support for early-stage bio and healthcare startups under 10 years Tenant Companies (As of June 2025): Total 126 companies (Digital Health 42 companies (33.3%), Pharmaceuticals 61 companies (48.5%), Medical Devices 23 companies (18.2%)) Infrastructure: Laboratories, office spaces, meeting rooms, conference rooms, research equipment (249 devices, 109 types, approximately $8 million scale) Research and Human Resource Network (Regional): Approximately 7,000 PhD-level personnel, approximately 120,000 university students, $1.13 billion in research funding, connections with 12 universities and research institutions and 7 hospitals Major Support Programs: IR matching and investment linkage Expert consulting and CEO education Hospital-linked clinical and data programs Open innovation with domestic and international pharmaceutical companies About Celltrion https://www.celltrion.com/en-us Establishment Date: February 26, 2002 Location (Headquarters): 23 Academy-ro, Yeonsu-gu, Incheon Metropolitan City, Republic of Korea Business Areas and Major Products (Services) Possessing Differentiated Integrated Solutions Across the Entire Biopharmaceutical Business Process Remsima: World’s first monoclonal antibody biosimilar (TNF-α inhibitor) Herzuma: Trastuzumab biosimilar for breast and gastric cancer treatment Truxima (CT-P10): Rituximab biosimilar (lymphoma, rheumatoid arthritis, etc.) Multiple products including Zymfentra, Yuflyma, Vegzelma, Steqeyma, Avtozma are under global approval and commercialization No of Employees: Approx. 3,003 (As of June 30, 2025) Media Contact Brand: SEOUL BIO HUB Contact: Lee Yoon Jin Phone: +82 02-2200-3345 Email: lynj@kist.re.kr Website: (KOR) https://www.seoulbiohub.kr/front/user/main.do; (ENG) https://www.seoulbiohub.kr/front/user/engmain.do

Ottawa, Canada – September 16, 2025 – (SeaPRwire) – Trading Central, a pioneer in financial market research and insights, announced the launch of FIBI, AI Assistant, across its suite of research tools: Technical Insight®, TC Options Insight, TC Fundamental Insight®, and TC Market Buzz®. FIBI (‘Financial Insight Bot Interface’) leverages Trading Central’s proprietary natural language processing (NLP), language model (LM), and generative AI (GenAI) technologies—trained by the company’s award-winning data scientists and financial analysts. These models are grounded in deep expertise across technical and fundamental analysis, options trading, and market behavior. FIBI sets itself apart from generic AI and chatbots with actionable and compliance-friendly market insights powered by high-quality, real-time data. Its natural language storytelling and progressive disclosure of key insights ensure that investors of all skill-levels benefit from quality analysis without the information overload. “FIBI represents the next generation of investor enablement,” said Alain Pellier, CEO of Trading Central. “In a world flooded with generic AI content, FIBI offers a focused, trustworthy experience that’s built for action.” With FIBI, brokers can deliver a differentiated client experience — empowering investors with a tool that feels insightful, approachable and personalized, while strengthening trust in their research offering. FIBI continues Trading Central’s mission to empower investors worldwide, bridging the gap between sophisticated analysis and actionable insights. Contact Trading Central today to book your demo at sales@tradingcentral.com. About Trading Central Since 1999, Trading Central has empowered investors to make confident decisions with actionable, award-winning research. By combining expert insights with modern data visualizations, Trading Central helps investors discover trade ideas, manage risk, and identify new opportunities. Its flexible tools are designed for seamless integration across desktop and mobile platforms via iFrames, APIs, and widgets. Media Contact Brand: Trading Central Melissa Dettorre, Marketing Manager Email: marketing@tradingcentral.com Website: https://www.tradingcentral.com

Taipei – September 15, 2025 – (SeaPRwire) – PopChill, Taiwan’s leading luxury resale platform, today announced the completion of its Series A funding round, raising US$3 million. This brings the company’s total funding to over US$9 million. The round was led by Darwin Ventures. Other participating investors include ITIC, AVA Angels, Taipei Angels (TA), and Dream coFounder. The new capital will be used to accelerate the development and application of AI technologies—including AI Agents, intelligent recommendation systems, and automated fraud prevention – aimed at upgrading the entire buyer and seller experience. Strong Growth Momentum, Cementing Market Leadership In 2024, PopChill’s transaction volume grew 120% year-over-year, reflecting robust market demand. With an average order value of US$900, the platform continues to demonstrate the deep potential of luxury resale. Cross-border transactions now account for nearly 20% of total GMV, with a solid foothold in Hong Kong and a growing global presence. The platform currently lists more than 100,000 luxury items, securing its position as Taiwan’s largest luxury resale marketplace. “Our vision is to use technology to solve inefficiencies in the luxury resale market,” said Andy Kuo, CEO of PopChill. “In the era of generative AI, PopChill is uniquely positioned to further enhance matching efficiency between buyers and sellers.” AI-Powered Innovation to Enhance User Experience At the heart of PopChill’s vision lies a belief that technology can make luxury resale seamless and trustworthy. Guided by this vision, the company is actively developing a new generation of AI tools designed to accompany both buyers and sellers throughout their journeys. The idea is to give buyers a personal shopping companion—an assistant that can one day quickly guide them to the item they have been dreaming of, shortening the path from discovery to purchase. On the seller side, PopChill is envisioning an AI partner that simplifies the listing process and ensures that details such as descriptions and categorization can be handled with ease. These initiatives are still in progress, but PopChill has already begun laying the groundwork by adopting Google Cloud Vertex AI to enhance efficiency and strengthen conversion rates. Rather than treating AI as a buzzword, the company is deliberately weaving it into its future roadmap—building toward a marketplace that is smarter, more intuitive, and more human-centered. Building a Complete Resale Ecosystem Since its early days, PopChill successfully overcame the “cold start” challenge and built a comprehensive C2C ecosystem. In addition to peer-to-peer resale, the company recently introduced a consignment model to serve sellers who prefer not to handle listings themselves. The model has already shown early success since its mid-year launch. Looking ahead, PopChill plans to establish brick-and-mortar stores to deepen online-offline integration, strengthen brand trust, and broaden consumer awareness—steps toward building a fully integrated luxury resale ecosystem. Media Contact Brand: PopChill Contact: Media team Email: support@popchill.com Website: https://www.popchill.com

New York, NY – September 01, 2025 – (SeaPRwire) – me88news, a dedicated sports journalism platform, announced its official launch today, designed to provide comprehensive coverage and expert analysis across four key competitive disciplines: Formula 1, E-sports, Badminton, and Martial Arts. Addressing the Information Gap in Sports Media The launch of me88 news responds to the growing demand for specialized sports content that goes beyond surface-level reporting. Unlike traditional sports platforms that prioritize click-driven headlines, me88 news focuses on delivering substantive analysis, technical breakdowns, and exclusive behind-the-scenes content that enhances readers’ understanding of competitive sports. “The sports media landscape is saturated with recycled content and sensational headlines,” said Owen Parker at me88 news. “Our platform represents a commitment to journalism that respects both the intelligence of our audience and the complexity of modern competitive sports.” Comprehensive Multi-Sport Coverage me88 news provides specialized reporting across four distinct sporting categories: Formula 1: Technical analysis covering paddock politics, pit lane strategies, and the engineering innovations that define modern motorsport E-sports: Tournament coverage, player profiles, and analysis of the rapidly evolving digital athletics landscape Badminton: In-depth coverage of one of the world’s most physically demanding racket sports, featuring tactical analysis and athlete profiles Martial Arts: Comprehensive reporting spanning traditional disciplines to modern competitive fighting, honoring both heritage and contemporary innovation Real-Time Global Coverage The platform operates with around-the-clock reporting capabilities, ensuring readers receive timely updates regardless of global time zones. Features include live event coverage, instant post-competition analysis, and multimedia content including highlight reels and exclusive interviews. Beyond breaking news, me88 news offers editorial content designed to foster informed discussion within the sports community, including opinion pieces, feature stories, and long-form investigations into the human stories behind athletic achievement. Industry Positioning and Future Outlook me88 news enters a competitive digital sports media market with a differentiated approach focused on quality over quantity. The platform’s launch reflects broader industry trends toward specialized content and expert analysis as audiences increasingly seek authoritative sources for sports information. The company plans to expand coverage areas and enhance multimedia offerings as the platform develops its audience base and establishes its position within the sports media ecosystem. About me88 news me88 news is a sports journalism platform dedicated to providing comprehensive coverage and analysis across multiple competitive disciplines. Through strategic partnerships and expert-driven content, me88 news serves sports enthusiasts seeking in-depth analysis that enhances their understanding and appreciation of competitive athletics. Media Contact Company: me88 news Contact: Media Team Email: hello@me88news.com Website: https://me88news.com/

New York, NY – September 01, 2025 – (SeaPRwire) – me88news, a dedicated sports journalism platform, announced its official launch today, designed to provide comprehensive coverage and expert analysis across four key competitive disciplines: Formula 1, E-sports, Badminton, and Martial Arts. Addressing the Information Gap in Sports Media The launch of me88 news responds to the growing demand for specialized sports content that goes beyond surface-level reporting. Unlike traditional sports platforms that prioritize click-driven headlines, me88 news focuses on delivering substantive analysis, technical breakdowns, and exclusive behind-the-scenes content that enhances readers’ understanding of competitive sports. “The sports media landscape is saturated with recycled content and sensational headlines,” said Owen Parker at me88 news. “Our platform represents a commitment to journalism that respects both the intelligence of our audience and the complexity of modern competitive sports.” Comprehensive Multi-Sport Coverage me88 news provides specialized reporting across four distinct sporting categories: Formula 1: Technical analysis covering paddock politics, pit lane strategies, and the engineering innovations that define modern motorsport E-sports: Tournament coverage, player profiles, and analysis of the rapidly evolving digital athletics landscape Badminton: In-depth coverage of one of the world’s most physically demanding racket sports, featuring tactical analysis and athlete profiles Martial Arts: Comprehensive reporting spanning traditional disciplines to modern competitive fighting, honoring both heritage and contemporary innovation Real-Time Global Coverage The platform operates with around-the-clock reporting capabilities, ensuring readers receive timely updates regardless of global time zones. Features include live event coverage, instant post-competition analysis, and multimedia content including highlight reels and exclusive interviews. Beyond breaking news, me88 news offers editorial content designed to foster informed discussion within the sports community, including opinion pieces, feature stories, and long-form investigations into the human stories behind athletic achievement. Industry Positioning and Future Outlook me88 news enters a competitive digital sports media market with a differentiated approach focused on quality over quantity. The platform’s launch reflects broader industry trends toward specialized content and expert analysis as audiences increasingly seek authoritative sources for sports information. The company plans to expand coverage areas and enhance multimedia offerings as the platform develops its audience base and establishes its position within the sports media ecosystem. About me88 news me88 news is a sports journalism platform dedicated to providing comprehensive coverage and analysis across multiple competitive disciplines. Through strategic partnerships and expert-driven content, me88 news serves sports enthusiasts seeking in-depth analysis that enhances their understanding and appreciation of competitive athletics. Media Contact Company: me88 news Contact: Media Team Email: hello@me88news.com Website: https://me88news.com/

New York, NY – August 28, 2025 – (SeaPRwire) – As part of its launch, Poolbetx (https://poolbetx.com) proudly introduces its Token (PBX), a stable crypto coin designed as a digital igaming chip for the Poolbetx ecosystem. Built on TON Blockchain: PBX runs on the highly scalable TON blockchain, ensuring speed, low fees, and reliability. Global Accessibility: PBX can be accessed and traded across all major DEX pools including DeDust.io and Ston.fi. Wallet Integration: Customers can easily buy, exchange, or cash out PBX tokens directly through Telegram Wallet and TON Hub Wallet, available on the Apple App Store and Google Play Store. Borderless & Jurisdiction-Free: PBX enables seamless global usage, allowing Poolbetx players to withdraw, play, and transact without jurisdictional restrictions – a world-first innovation in crypto igaming platforms. “PBX is more than a token – it’s a bridge between our global customers and the Poolbetx ecosystem,” said a Poolbetx spokesperson. “By making PBX accessible on everyday apps like Telegram and Tonhub, we’re ensuring anyone, anywhere, can join Poolbetx with ease.” With PBX, Poolbetx not only provides premium i- games but also a financial infrastructure that redefines global access to entertainment. Related Links Telegram: https://t.me/poolbetx PBX on DeDust: https://dedust.io/ PBX on Stonfi: https://ston.fi/ Media contact Brand: Poolbetx Contact: media team Email: support@poolbetx.com Website: https://poolbetx.com

New York, NY – August 28, 2025 – (SeaPRwire) – As part of its launch, Poolbetx (https://poolbetx.com) proudly introduces its Token (PBX), a stable crypto coin designed as a digital igaming chip for the Poolbetx ecosystem. Built on TON Blockchain: PBX runs on the highly scalable TON blockchain, ensuring speed, low fees, and reliability. Global Accessibility: PBX can be accessed and traded across all major DEX pools including DeDust.io and Ston.fi. Wallet Integration: Customers can easily buy, exchange, or cash out PBX tokens directly through Telegram Wallet and TON Hub Wallet, available on the Apple App Store and Google Play Store. Borderless & Jurisdiction-Free: PBX enables seamless global usage, allowing Poolbetx players to withdraw, play, and transact without jurisdictional restrictions – a world-first innovation in crypto igaming platforms. “PBX is more than a token – it’s a bridge between our global customers and the Poolbetx ecosystem,” said a Poolbetx spokesperson. “By making PBX accessible on everyday apps like Telegram and Tonhub, we’re ensuring anyone, anywhere, can join Poolbetx with ease.” With PBX, Poolbetx not only provides premium i- games but also a financial infrastructure that redefines global access to entertainment. Related Links Telegram: https://t.me/poolbetx PBX on DeDust: https://dedust.io/ PBX on Stonfi: https://ston.fi/ Media contact Brand: Poolbetx Contact: media team Email: support@poolbetx.com Website: https://poolbetx.com

New York, NY – August 27, 2025 – (SeaPRwire) – T-RIZE Group, a global fintech firm offering institutional-grade tokenization infrastructure, is launching Vision 60 by Ste-Rose, a $24.2 million, 60-unit energy-efficient residential development in Laval, Québec. This project is part of a 500+ unit new construction deal with T-RIZE Group, valued at $200 million. Tokenized by T-RIZE, the offering is being launched through a strategic collaboration with Republic, one of the world’s leading regulated investment platforms with over 3 million users, $3 billion in deployed capital, and more than 2,500 ventures backed. Accredited investors will be able to participate using both fiat and cryptocurrency. Pipeline Execution in Motion Vision 60 by Ste-Rose follows Vision 87 by Champfleury, an 87-unit, $23 million tokenized offering that forms part of a separate $300 million, 956-unit residential development. Together, these offerings reflect the ongoing execution of T-RIZE’s multi-billion-dollar pipeline, applying a scalable, compliant framework for bringing real-world assets onchain. T-RIZE leads tokenization, including asset digitization, legal structuring, and smart contract deployment. Republic’s affiliate broker-dealer, OpenDeal Broker LLC , Member FINRA & SiPC, oversees investor onboarding and distribution under Regulation D. Token-Powered Infrastructure Vision 60 will be deployed on an EVM-compatible blockchain such as Base or Avalanche, two leading infrastructures supporting institutional adoption of real-world assets. Base, incubated by Coinbase, enables low-cost execution, robust security, and seamless integration with Ethereum and capital markets ecosystems, offering a strong foundation for tokenized financial products. Avalanche delivers high-performance infrastructure with flexible tooling, supporting regulatory alignment and scalable deployment of institutional tokenization use cases. The $RIZE utility token anchors the T-RIZE ecosystem. It is used to access and pay for tokenization services—including onboarding, structuring, and listing—while also unlocking vetted investment opportunities, enabling decentralized governance, and supporting ecosystem growth. With 30% of supply allocated to governance and incentives, $RIZE is listed on tier-1 venues like Kraken and Revolut. Built with Institutional-Grade Standards Vision 60 is supported by a network of third-party experts and institutions: ● Ekitas – Legal and tax structuring ● CBRE – Independent project appraisal ● BDO – Return and cash flow projections ● Intact Insurance – Performance bond underwriting ● MA2D – Lead developer ● Concept Habitation Duo Inc. – Property manager ● Republic – Regulated global investment platform T-RIZE also operates as a validator and RWA issuer on the Canton Network, a privacy-first blockchain used by institutions such as Goldman Sachs, Broadridge, and Cumberland, where over $2 trillion in monthly transactions are settled and more than $4 trillion in digital assets are safeguarded. This positions T-RIZE at the intersection of regulated finance and onchain innovation. “Tokenized real estate is no longer a concept—it’s entering its institutional growth phase,” said Madani Boukalba, CEO of T-RIZE Group. “Vision 60 is a real-world proof point of how scalable, compliant infrastructure unlocks global access to tokenized real estate—setting the stage for broader institutional adoption.” About Republic Headquartered in New York City, Republic is a global financial firm operating a network of retail-focused investment platforms and an enterprise digital advisory arm. With a deep track record of legal and technical innovation, Republic is known for providing access to new asset classes to investors of all types. Backed by Valor Equity Partners, Galaxy Interactive, HOF Capital, AngelList and other leading institutions, Republic boasts a global portfolio of over 2,000 companies and a community of nearly three million members in over 150 countries. More than $3 billion has been deployed through investment platforms, funds, and firms within the Republic family of companies with operations established in the US, the UK, EU, the UAE and South Korea. All broker-dealer related securities activity is conducted by OpenDeal Broker LLC, an affiliate of OpenDeal Inc. a registered broker-dealer, and member of FINRA | SiPC, located at 149 5th Avenue, 10th FL, New York, 10010 please check our background on FINRA’s BrokerCheck and Form CRS here. For additional information, visit https://republic.com/ About T-RIZE Group Founded in 2022, T-RIZE is an institutional tokenization platform onboarding a multi-billion-dollar pipeline of real estate, structured financial products, and AI Energy Offset Reserve Notes. The T-RIZE platform transforms these assets into programmable digital instruments that unlock liquidity, lower capital costs, and enhance underwriting and risk modelling while protecting sensitive data through privacy-preserving AI. At its core, the RIZE token powers tokenization services, connects institutions to vetted investments and AI-driven infrastructure, and supports governance and incentive programs across the ecosystem. For more information, visit www.T-RIZE.io or contact: Press Inquiries: press@T-RIZE.io Head Office: 1155 René-Lévesque West, Suite 2500, Montreal, QC H3B 3X7, Canada Toronto Office: 130 King Street West, Suite 1900, Toronto, ON M5X 1E3, Canada

New York, NY – August 27, 2025 – (SeaPRwire) – T-RIZE Group, a global fintech firm offering institutional-grade tokenization infrastructure, is launching Vision 60 by Ste-Rose, a $24.2 million, 60-unit energy-efficient residential development in Laval, Québec. This project is part of a 500+ unit new construction deal with T-RIZE Group, valued at $200 million. Tokenized by T-RIZE, the offering is being launched through a strategic collaboration with Republic, one of the world’s leading regulated investment platforms with over 3 million users, $3 billion in deployed capital, and more than 2,500 ventures backed. Accredited investors will be able to participate using both fiat and cryptocurrency. Pipeline Execution in Motion Vision 60 by Ste-Rose follows Vision 87 by Champfleury, an 87-unit, $23 million tokenized offering that forms part of a separate $300 million, 956-unit residential development. Together, these offerings reflect the ongoing execution of T-RIZE’s multi-billion-dollar pipeline, applying a scalable, compliant framework for bringing real-world assets onchain. T-RIZE leads tokenization, including asset digitization, legal structuring, and smart contract deployment. Republic’s affiliate broker-dealer, OpenDeal Broker LLC , Member FINRA & SiPC, oversees investor onboarding and distribution under Regulation D. Token-Powered Infrastructure Vision 60 will be deployed on an EVM-compatible blockchain such as Base or Avalanche, two leading infrastructures supporting institutional adoption of real-world assets. Base, incubated by Coinbase, enables low-cost execution, robust security, and seamless integration with Ethereum and capital markets ecosystems, offering a strong foundation for tokenized financial products. Avalanche delivers high-performance infrastructure with flexible tooling, supporting regulatory alignment and scalable deployment of institutional tokenization use cases. The $RIZE utility token anchors the T-RIZE ecosystem. It is used to access and pay for tokenization services—including onboarding, structuring, and listing—while also unlocking vetted investment opportunities, enabling decentralized governance, and supporting ecosystem growth. With 30% of supply allocated to governance and incentives, $RIZE is listed on tier-1 venues like Kraken and Revolut. Built with Institutional-Grade Standards Vision 60 is supported by a network of third-party experts and institutions: ● Ekitas – Legal and tax structuring ● CBRE – Independent project appraisal ● BDO – Return and cash flow projections ● Intact Insurance – Performance bond underwriting ● MA2D – Lead developer ● Concept Habitation Duo Inc. – Property manager ● Republic – Regulated global investment platform T-RIZE also operates as a validator and RWA issuer on the Canton Network, a privacy-first blockchain used by institutions such as Goldman Sachs, Broadridge, and Cumberland, where over $2 trillion in monthly transactions are settled and more than $4 trillion in digital assets are safeguarded. This positions T-RIZE at the intersection of regulated finance and onchain innovation. “Tokenized real estate is no longer a concept—it’s entering its institutional growth phase,” said Madani Boukalba, CEO of T-RIZE Group. “Vision 60 is a real-world proof point of how scalable, compliant infrastructure unlocks global access to tokenized real estate—setting the stage for broader institutional adoption.” About Republic Headquartered in New York City, Republic is a global financial firm operating a network of retail-focused investment platforms and an enterprise digital advisory arm. With a deep track record of legal and technical innovation, Republic is known for providing access to new asset classes to investors of all types. Backed by Valor Equity Partners, Galaxy Interactive, HOF Capital, AngelList and other leading institutions, Republic boasts a global portfolio of over 2,000 companies and a community of nearly three million members in over 150 countries. More than $3 billion has been deployed through investment platforms, funds, and firms within the Republic family of companies with operations established in the US, the UK, EU, the UAE and South Korea. All broker-dealer related securities activity is conducted by OpenDeal Broker LLC, an affiliate of OpenDeal Inc. a registered broker-dealer, and member of FINRA | SiPC, located at 149 5th Avenue, 10th FL, New York, 10010 please check our background on FINRA’s BrokerCheck and Form CRS here. For additional information, visit https://republic.com/ About T-RIZE Group Founded in 2022, T-RIZE is an institutional tokenization platform onboarding a multi-billion-dollar pipeline of real estate, structured financial products, and AI Energy Offset Reserve Notes. The T-RIZE platform transforms these assets into programmable digital instruments that unlock liquidity, lower capital costs, and enhance underwriting and risk modelling while protecting sensitive data through privacy-preserving AI. At its core, the RIZE token powers tokenization services, connects institutions to vetted investments and AI-driven infrastructure, and supports governance and incentive programs across the ecosystem. For more information, visit www.T-RIZE.io or contact: Press Inquiries: press@T-RIZE.io Head Office: 1155 René-Lévesque West, Suite 2500, Montreal, QC H3B 3X7, Canada Toronto Office: 130 King Street West, Suite 1900, Toronto, ON M5X 1E3, Canada

PALM BEACH, FL – August 25, 2025 – (SeaPRwire) – BlackRidge & Co, an elite global advisory firm, announced that it has established its official headquarters in Palm Beach, Florida, as the region cements its reputation as “Wall Street South.” The move places the firm at the center of one of the fastest-growing financial hubs in the United States, with additional offices in New York, Silicon Valley, London, and Hong Kong. To learn more about BlackRidge & Co, visit www.blackridgeandco.com The BlackRidge & Co leadership team brings a heritage of advising the most prestigious institutions, including Rothschild Asset Management, Deutsche Bank, and ICBC Hong Kong. Beyond advisory services, the firm’s specialty is orchestrating introductions to capital, forging strategic growth partnerships, and working alongside clients to unlock new markets and drive long-term value creation. “At BlackRidge & Co, our mission is to create opportunities that are often inaccessible through traditional channels—pairing extraordinary companies with the investors and capital they need to scale globally,” said Director of Communications, Isaac Meyer. The migration of capital and talent into South Florida has reshaped the financial landscape. Since Ken Griffin’s Citadel relocated from Chicago to Miami in 2022, major institutions including Goldman Sachs, Blackstone, and Peter Thiel’s Founders Fund have followed, creating a powerful concentration of wealth and influence. Palm Beach has emerged as the crown jewel of this movement, now home to more than 300 hedge funds, private equity firms, and financial institutions. A 2025 Forbes analysis reports that at least 68 billionaires maintain strong ties to Palm Beach, underscoring its position as a magnet for global wealth. About BlackRidge & Co BlackRidge & Co is a global advisory firm headquartered in Palm Beach with hubs in New York, Silicon Valley, London, and Hong Kong. The firm specializes in capital introductions, connecting visionary companies with the world’s most influential financiers, investors, and lenders. Through cultivated relationships and decades of experience, BlackRidge helps clients unlock new opportunities, build partnerships, and create sustainable growth. Media contact Brand: BlackRidge & Co Contact: Isaac Meyer, Director of Communications E-mail: im@blackridgeandco.com Website: https://www.blackridgeandco.com

PALM BEACH, FL – August 25, 2025 – (SeaPRwire) – BlackRidge & Co, an elite global advisory firm, announced that it has established its official headquarters in Palm Beach, Florida, as the region cements its reputation as “Wall Street South.” The move places the firm at the center of one of the fastest-growing financial hubs in the United States, with additional offices in New York, Silicon Valley, London, and Hong Kong. To learn more about BlackRidge & Co, visit www.blackridgeandco.com The BlackRidge & Co leadership team brings a heritage of advising the most prestigious institutions, including Rothschild Asset Management, Deutsche Bank, and ICBC Hong Kong. Beyond advisory services, the firm’s specialty is orchestrating introductions to capital, forging strategic growth partnerships, and working alongside clients to unlock new markets and drive long-term value creation. “At BlackRidge & Co, our mission is to create opportunities that are often inaccessible through traditional channels—pairing extraordinary companies with the investors and capital they need to scale globally,” said Director of Communications, Isaac Meyer. The migration of capital and talent into South Florida has reshaped the financial landscape. Since Ken Griffin’s Citadel relocated from Chicago to Miami in 2022, major institutions including Goldman Sachs, Blackstone, and Peter Thiel’s Founders Fund have followed, creating a powerful concentration of wealth and influence. Palm Beach has emerged as the crown jewel of this movement, now home to more than 300 hedge funds, private equity firms, and financial institutions. A 2025 Forbes analysis reports that at least 68 billionaires maintain strong ties to Palm Beach, underscoring its position as a magnet for global wealth. About BlackRidge & Co BlackRidge & Co is a global advisory firm headquartered in Palm Beach with hubs in New York, Silicon Valley, London, and Hong Kong. The firm specializes in capital introductions, connecting visionary companies with the world’s most influential financiers, investors, and lenders. Through cultivated relationships and decades of experience, BlackRidge helps clients unlock new opportunities, build partnerships, and create sustainable growth. Media contact Brand: BlackRidge & Co Contact: Isaac Meyer, Director of Communications E-mail: im@blackridgeandco.com Website: https://www.blackridgeandco.com

Hunet Plus Co., Ltd. (CEO Hyukjin Cha), a company specializing in next-generation semiconductor and display materials, announced on Aug. 13th that it has secured Pre-Series B investment for entry into the U.S. market from global semiconductor-related companies, including strategic investors from Japan and Taiwan, as well as the Korean financial investor, ANDA Asia Ventures. In particular, this investment – secured at a time when US and Korea’s tariff issues in the semiconductor sector are coming to the forefront – marks a significant milestone, as it has attracted investment from leading investors from Korea, Japan, and Taiwan. The deal is expected to provide strong momentum not only for securing the original technology of ML-EUV® (Molecular Layer Assembled Extreme UltraViolet Technology, Process and Materials – a multilayer molecular film vacuum process-type photoresist for extreme ultraviolet lithography), but also for obtaining international patents to support market entry into the U.S., Japan and global markets. Furthermore, as one of the few Korean start-up companies to successfully attract foreign investment from Japan and Taiwan, Hunet Plus is expected to gain strong traction in expanding its markets while strengthening its global competitiveness. ML-EUV® is a next-generation total solution for EUV (Extreme Ultraviolet) lithography, encompassing vertically stacked molecular structures, manufacturing processes, and materials. Hunet Plus’ ML-EUV® has overcome the limitations of achieving ultra-high resolution (below 10 nm line width) and sub-2 nm line edge roughness (LER), which have been difficult to realize with existing methods such as: Second-generation chemical amplification resists (wet process, Chemical Amplification Resist) Third-generation inorganic nano-cluster-based resists (wet process, Nano Cluster Based Resist) Fourth-generation inorganic dry-process resists (dry process, Inorganic Precursor Resist) Hunet Plus’ ML-EUV® achieves world-class performance of ultra-high resolution below 10 nm and line edge roughness below 2 nm by using organic precursors and inorganic precursors at the molecular level, forming 10–20 nm ultra-thin multi-layered resist films through its proprietary Organic–Inorganic Molecular Layer Deposition Process® – an innovative dry molecular-layer stacking method. Through this strategic investment, Hunet Plus has formally launched commercialization efforts for ML-EUV®. Based on the world’s highest-performing ML-EUV®, the company plans to jointly commercialize ML-EUV® equipment and processes for dry processing with leading global semiconductor equipment manufacturers, while also supplying core organic and inorganic process materials for ML-EUV®-related semiconductor processes in partnership with global materials companies. In doing so, Hunet Plus aims to position itself as a key player in the semiconductor materials, components, and equipment sector. Hyukjin Cha, CEO of Hunet Plus, stated: “In the global semiconductor market, national borders no longer matter. In the near future, technologies and products like our ML-EUV® – innovative and market-leading – will be the basis for global companies to collaborate and build ecosystems that dominate the market and ensure sustainability. We anticipate additional USD 10 Million follow-on investments from our existing shareholders as well as other global companies, including in the U.S., and will work with local clients to build unique and sustainable ecosystem.” Haesun Kim, Senior Executive Director of HunetPlus, who played a pivotal role in leading the successful domestic and overseas fundraising, drew on more than 25 years of professional experience in international finance and foreign capital attraction, commented: “Although the past two years have been a very challenging period for Hunet Plus – requiring not only navigating detailed and rigorous due diligence imposed by top-tier international investors but also had to lead strategic negotiations – it has been deeply rewarding. In particular, despite a difficult investment climate as well as attracting interest from potential investors to one of the top level industries in the world, this has become a meaningful success story made possible by the organic cooperation with HunetPlus executives.” Cho Namhoon, CEO of K-Ground Ventures, an existing investor and the operator of Scale-Up TIPS who provided behind-the-scenes support for this investment, said: “Even in Korea’s challenging environment for bold investments in original technology, we had a strong belief in Hunet Plus’ global-standard R&D capabilities. Through the Hongneung Advanced Science & Technology Commercialization Fund, we took the bold step of making an early-stage investment, followed by support for subsequent fundraising, reinvestment through the Innovation IP Fund, and additional backing via Scale-Up TIPS. This long-term investment strategy has brought significant results. In particular, the attracting investment from renowned global investors is expected to support U.S. market entry and lead to further follow-on investments, ultimately building a sustainable global supply ecosystem for Korean semiconductor technology through joint Korea–U.S. R&D, production, and marketing.” Meanwhile, on August 6 (local time), U.S. President Donald Trump, at an Apple facility investment announcement event, stated, “We will impose 100% tariffs on every semiconductor imported into the United States.” This announcement has drawn intense attention from semiconductor startups and investors, as semiconductors are the second-largest category of U.S.-bound exports, especially ahead of the upcoming Korea–U.S. summit, where the government’s response will be closely watched. Media contact Brand: Hunet Plus Contact: Hyukjin Cha, CEO Email: support@hunetplus.com Telephone: +82-10-8817-0003 Website: https://en.hunetplus.com

Hunet Plus Co., Ltd. (CEO Hyukjin Cha), a company specializing in next-generation semiconductor and display materials, announced on Aug. 13th that it has secured Pre-Series B investment for entry into the U.S. market from global semiconductor-related companies, including strategic investors from Japan and Taiwan, as well as the Korean financial investor, ANDA Asia Ventures. In particular, this investment – secured at a time when US and Korea’s tariff issues in the semiconductor sector are coming to the forefront – marks a significant milestone, as it has attracted investment from leading investors from Korea, Japan, and Taiwan. The deal is expected to provide strong momentum not only for securing the original technology of ML-EUV® (Molecular Layer Assembled Extreme UltraViolet Technology, Process and Materials – a multilayer molecular film vacuum process-type photoresist for extreme ultraviolet lithography), but also for obtaining international patents to support market entry into the U.S., Japan and global markets. Furthermore, as one of the few Korean start-up companies to successfully attract foreign investment from Japan and Taiwan, Hunet Plus is expected to gain strong traction in expanding its markets while strengthening its global competitiveness. ML-EUV® is a next-generation total solution for EUV (Extreme Ultraviolet) lithography, encompassing vertically stacked molecular structures, manufacturing processes, and materials. Hunet Plus’ ML-EUV® has overcome the limitations of achieving ultra-high resolution (below 10 nm line width) and sub-2 nm line edge roughness (LER), which have been difficult to realize with existing methods such as: Second-generation chemical amplification resists (wet process, Chemical Amplification Resist) Third-generation inorganic nano-cluster-based resists (wet process, Nano Cluster Based Resist) Fourth-generation inorganic dry-process resists (dry process, Inorganic Precursor Resist) Hunet Plus’ ML-EUV® achieves world-class performance of ultra-high resolution below 10 nm and line edge roughness below 2 nm by using organic precursors and inorganic precursors at the molecular level, forming 10–20 nm ultra-thin multi-layered resist films through its proprietary Organic–Inorganic Molecular Layer Deposition Process® – an innovative dry molecular-layer stacking method. Through this strategic investment, Hunet Plus has formally launched commercialization efforts for ML-EUV®. Based on the world’s highest-performing ML-EUV®, the company plans to jointly commercialize ML-EUV® equipment and processes for dry processing with leading global semiconductor equipment manufacturers, while also supplying core organic and inorganic process materials for ML-EUV®-related semiconductor processes in partnership with global materials companies. In doing so, Hunet Plus aims to position itself as a key player in the semiconductor materials, components, and equipment sector. Hyukjin Cha, CEO of Hunet Plus, stated: “In the global semiconductor market, national borders no longer matter. In the near future, technologies and products like our ML-EUV® – innovative and market-leading – will be the basis for global companies to collaborate and build ecosystems that dominate the market and ensure sustainability. We anticipate additional USD 10 Million follow-on investments from our existing shareholders as well as other global companies, including in the U.S., and will work with local clients to build unique and sustainable ecosystem.” Haesun Kim, Senior Executive Director of HunetPlus, who played a pivotal role in leading the successful domestic and overseas fundraising, drew on more than 25 years of professional experience in international finance and foreign capital attraction, commented: “Although the past two years have been a very challenging period for Hunet Plus – requiring not only navigating detailed and rigorous due diligence imposed by top-tier international investors but also had to lead strategic negotiations – it has been deeply rewarding. In particular, despite a difficult investment climate as well as attracting interest from potential investors to one of the top level industries in the world, this has become a meaningful success story made possible by the organic cooperation with HunetPlus executives.” Cho Namhoon, CEO of K-Ground Ventures, an existing investor and the operator of Scale-Up TIPS who provided behind-the-scenes support for this investment, said: “Even in Korea’s challenging environment for bold investments in original technology, we had a strong belief in Hunet Plus’ global-standard R&D capabilities. Through the Hongneung Advanced Science & Technology Commercialization Fund, we took the bold step of making an early-stage investment, followed by support for subsequent fundraising, reinvestment through the Innovation IP Fund, and additional backing via Scale-Up TIPS. This long-term investment strategy has brought significant results. In particular, the attracting investment from renowned global investors is expected to support U.S. market entry and lead to further follow-on investments, ultimately building a sustainable global supply ecosystem for Korean semiconductor technology through joint Korea–U.S. R&D, production, and marketing.” Meanwhile, on August 6 (local time), U.S. President Donald Trump, at an Apple facility investment announcement event, stated, “We will impose 100% tariffs on every semiconductor imported into the United States.” This announcement has drawn intense attention from semiconductor startups and investors, as semiconductors are the second-largest category of U.S.-bound exports, especially ahead of the upcoming Korea–U.S. summit, where the government’s response will be closely watched. Media contact Brand: Hunet Plus Contact: Hyukjin Cha, CEO Email: support@hunetplus.com Telephone: +82-10-8817-0003 Website: https://en.hunetplus.com

SHENZHEN, CHINA, Aug 19, 2025 – (ACN Newswire via SeaPRwire.com) – On 18 August, China Medical System Holdings Limited (“CMS” or the “Company”) announced its interim results for the six months ended 30 June 2025 (the “Reporting Period”), with both revenue and profit recording year-on-year growth, demonstrating the initial results of its strategic transformation. During the Reporting Period, the Company recorded revenue of approximately RMB4.00 billion, representing a year-on-year increase of 10.8%. In the case that all medicines were directly sold by the Company, revenue would be approximately RMB4.67 billion, up 8.9% year-on-year. Net profit was approximately RMB0.93 billion, representing an increase of 3.1% year-on-year. The results reflect that CMS has emerged from the shadow of National Volume-based Procurement (“National VBP”), and its performance is expected to return to a sustainable growth trajectory. Revenue from the Company’s key non-National VBP exclusive/branded products and innovative products (in the case that all medicines were directly sold by the Company) reached approximately RMB2.90 billion, up 20.6% year-on-year, accounting for 62.1% of total revenue. The company’s exclusive/branded products and innovative products have a favorable competitive landscape and high visibility of future growth, and have now become the main drivers of performance growth. According to the interim results announcement, the company has been planning its “New CMS” blueprint since 2018, anchored on the three strategic pillars of “product innovation, commercial model reform, and international expansion” to build a sustainable second growth curve. By the first half of 2025, solid operating results and the steady delivery of innovation outcomes have confirmed that the Company’s strategic upgrade has been gradually translated into tangible achievements. “New Products” Strategy Drives Innovation Value Realization and Solidifies Growth Momentum At the forefront of the Company’s three strategic pillars, the “product innovation” strategy leverages a three-dimensional innovation mechanism of “overseas licensing, domestic collaboration, and in-house R&D” to continuously inject high-value short-, medium- and long-term pipelines, serving as a key growth engine. Currently, the innovation strategy has entered a period of continuous harvest, with new products continuously releasing commercial and clinical value. To date, the Company has successfully commercialized five innovative drugs in China; By 2025, two innovative products — ruxolitinib cream and Desidustat Tablets—are also expected to receive marketing approvals. Ruxolitinib cream is the first and only topical JAK inhibitor approved by the U.S. FDA and the European Medicines Agency for repigmentation in non-segmental vitiligo, and is expected to become the first approved treatment for vitiligo in China, filling a market gap and bringing new hope to Chinese vitiligo patients. Additionally, the New Drug Application (NDA) for the Alzheimer’s disease drug ZUNVEYL in China was accepted in July this year; the consumer healthcare product Poly-L-lactic Acid Microparticle Filler Injection has been approved for marketing, further enriching the Company’s diversified product portfolio. Among the innovative pipeline under R&D, several blockbuster candidates have entered the late-stage clinical development in China and are expected to be commercialized within the next one to three years, forming a new driving force for sustained growth. Among these, the collaborative product Y-3 for Injection has completed Phase III clinical trials in China. This product is an original unimolecular Class 1 innovative drug and the only non-peptide PSD95/nNOS uncoupler that has entered clinical development, with potential to become the first dual-function brain cytoprotectant for treating ischemic stroke while preventing post-stroke depression and anxiety. Another oral small molecule Class 1 innovative drug, ABP-671 (a URAT1 inhibitor) for the treatment of gout and hyperuricemia, is progressing through Phase IIb/III clinical trials in China. Compared with existing mainstream drugs, ABP-671 has the potential to reduce uric acid to lower levels at lower doses and possesses gout-tophus dissolution capability, thereby offering patients a more effective and safer treatment option. CMS continues to expand its innovative pipeline and enhance its end-to-end innovation capabilities to ensure the steady, phased marketing approval of innovative products. In H1 2025, two new collaborative R&D innovative products — ZUNVEYL and MG-K10 (a long-acting anti-IL-4Rα humanized monoclonal antibody injection) — were added to the portfolio. To date, the Company has deployed about 40 differentiated innovative pipeline products, including approximately 20 in-house R&D projects. Advancing “New Models” and “New Markets” Strategies to Unlock Multi-dimensional Growth According to the interim results announcement, CMS continues to advance its “New Models — Commercial Model Reform” strategy, forging anti-cyclical resilience through a diversified ecosystem. It also firmly implements its “New Markets – International Expansion” strategy, building a multi-dimensional growth framework via an industrial internationalization model. Under the commercial model reform strategy, the Company continues to focus on specialty therapeutic fields while expanding into new retail and new media channels, building a comprehensive marketing and promotion system that covers both “in-hospital + out-of-hospital” and “online + offline” channels, and reinforcing its diversified product portfolio with consumer attributes. Its skin health business, Dermavon, has demonstrated strong potential in this particular segment with consumer attributes. Since its independent operation in 2021, Dermavon has achieved dual leadership in both the “coverage of dermatology indications” and the “revenue scale of dermatological prescription drugs”, and is proposed to be spun off and separately listed on the Main Board of the Hong Kong Stock Exchange by way of introduction and distribution in specie, to further unlock its standalone value and high-growth potential. In terms of internationalization, CMS successfully completed its secondary listing on the Main Board of the Singapore Exchange by way of introduction on 15 July 2025, marking a new milestone in its “industrial internationalization” strategy. With Singapore as a hub, the Company has established a comprehensive business system covering the entire value chain of “R&D–Manufacturing–Commercialization” for emerging markets. To date, its commercial platform company, Rxilient, has cumulatively submitted nearly 20 registration applications for pharmaceutical products and medical devices across Southeast Asia, the Middle East, Hong Kong, Macau, and Taiwan Region, covering therapeutic fields such as dermatology, ophthalmology, oncology, autoimmune, and central nervous system. Ruxolitinib cream (vitiligo indication) has been approved for marketing in Macau and Hong Kong, and its registration applications have been submitted in Singapore and Taiwan Region. Intravenous Toripalimab (the first China-originated anti-PD-1 monoclonal antibody drug that has been approved by the China NMPA and the U.S. FDA) has been submitted for registration in five countries, including Malaysia. Tildrakizumab Injection and Sucroferric Oxyhydroxide Chewable Tablets have also been approved for marketing in Hong Kong. Meanwhile, PharmaGend, an associate CDMO manufacturing facility in which CMS holds a 45.0% equity interest, now has an annual production capacity of 1 billion units of oral solid dosage forms (tablets and capsules), and has obtained a drug manufacturing license from Singapore’s HSA, U.S. FDA cGMP certification, and passed Swiss QP audits. The construction of new production lines for nasal sprays, creams, and injectables is progressing steadily, providing high-standard production and delivery capabilities for the international market. Looking ahead, the growth logic of “New CMS” is expected to accelerate its realization, with profitability and performance resilience improving simultaneously. The Company is building a growth framework centered on differentiated innovation, driven by a synergistic and diversified ecosystem, and underpinned by an international footprint. This will open up long-term opportunities for high-quality development, deliver quality pharmaceutical products and services to patients worldwide, and generate sustainable returns for shareholders. About CMS CMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs. CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients. CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development of its advantageous specialty fields and expand business boundaries, strengthening the competitiveness of the cardio-cerebrovascular/gastroenterology/ophthalmology/ skin health businesses. Among them, the skin health business has become a leading enterprise in its field, bringing economies of scale in specialty therapeutic fields. Meanwhile, CMS continuously deepens its business development in the Southeast Asia and Middle East regions, further escorting the sustainable and healthy development. CMS Disclaimer and Forward-Looking Statements This press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert. This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections. Media ContactBrand: China Medical System Holdings Ltd.Contact: CMS Investor RelationsEmail: ir@cms.net.cnWebsite: https://web.cms.net.cn/en/home/ Source: China Medical System Holdings Ltd. Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com Categories: ACN Newswire

Linyi, Shandong, Aug 13, 2025 – (ACN Newswire via SeaPRwire.com) – The 74th China (Linyi) International Hardware Expo, one of Asia’s most established industry gatherings with a history dating back to 1952, is set to take place from September 5–7, 2025 at the Linyi International Exhibition Center in Shandong, China. Hosted by the China Hardware, Electrical Equipment, and Chemicals Association, the event will bring together over 1,700 manufacturers and showcase more than 150,000 products across the hardware, tools, machinery, and building solutions sectors. Recognized as China’s largest hardware production and logistics hub, Linyi will welcome global buyers to engage directly with factories producing a wide range of products, including hand and power tools, woodworking equipment, welding systems, abrasives, fasteners, protective gear, LED lighting, plumbing, sanitary ware, and decorative materials. The expo offers multiple advantages for international participants, such as factory-direct sourcing with competitive pricing, customizable orders, and quality assurance. Organizers will provide free accommodation, flights, and meals for qualified overseas buyers, along with B2B matchmaking services, on-site order processing, and logistical support. Additional benefits include language interpretation, guided factory tours, and assistance with export procedures. Beyond the exhibition hall, attendees can explore the Linyi Hardware Market—Asia’s largest permanent trade center—for bulk negotiations and production line inspections, further strengthening opportunities for global collaboration in the hardware industry. Media ContactCompany: Beijing Jinyi Youlian Exhibition Co., Ltd.Contact Person: VincyTel: 86-10-63356966Fax: 86-10-63356950Address: 9th Floor, Fortune West Plaza, 58 Caihuying, Fengtai District, Beijing, 100054, ChinaEmail: hardwarefair@163.comWebsite: https://www.hardware-fair.com/p/EN.htmlhttps://www.qjwjh.com/p/EN.html Copyright 2025 ACN Newswire via SeaPRwire.com.

Linyi, Shandong, Aug 13, 2025 – (ACN Newswire via SeaPRwire.com) – The 74th China (Linyi) International Hardware Expo, one of Asia’s most established industry gatherings with a history dating back to 1952, is set to take place from September 5–7, 2025 at the Linyi International Exhibition Center in Shandong, China. Hosted by the China Hardware, Electrical Equipment, and Chemicals Association, the event will bring together over 1,700 manufacturers and showcase more than 150,000 products across the hardware, tools, machinery, and building solutions sectors. Recognized as China’s largest hardware production and logistics hub, Linyi will welcome global buyers to engage directly with factories producing a wide range of products, including hand and power tools, woodworking equipment, welding systems, abrasives, fasteners, protective gear, LED lighting, plumbing, sanitary ware, and decorative materials. The expo offers multiple advantages for international participants, such as factory-direct sourcing with competitive pricing, customizable orders, and quality assurance. Organizers will provide free accommodation, flights, and meals for qualified overseas buyers, along with B2B matchmaking services, on-site order processing, and logistical support. Additional benefits include language interpretation, guided factory tours, and assistance with export procedures. Beyond the exhibition hall, attendees can explore the Linyi Hardware Market—Asia’s largest permanent trade center—for bulk negotiations and production line inspections, further strengthening opportunities for global collaboration in the hardware industry. Media ContactCompany: Beijing Jinyi Youlian Exhibition Co., Ltd.Contact Person: VincyTel: 86-10-63356966Fax: 86-10-63356950Address: 9th Floor, Fortune West Plaza, 58 Caihuying, Fengtai District, Beijing, 100054, ChinaEmail: hardwarefair@163.comWebsite: https://www.hardware-fair.com/p/EN.htmlhttps://www.qjwjh.com/p/EN.html Copyright 2025 ACN Newswire via SeaPRwire.com.

Los Angeles, CA – August 10, 2025 – (SeaPRwire) – The Intervision’25 International Music Contest is set to take place in Moscow on September 20th, 2025, promising a high-profile celebration of global musical talent. In connection with the event, there is growing buzz suggesting that a descendant of Michael Jackson may be among the participants, though this remains unconfirmed. The 2025 edition is expected to offer a high-quality production with elaborate stage designs and will likely attract significant media attention. And it is expected to host artists from more than 20 countries, each presenting a musical style that reflects their culture. Choosing a representative tied to a legendary musical legacy could be a strategic move to capture the attention of global audiences. Michael Jackson’s connection to Russia is well-documented, as he performed twice in Moscow. His first visit was in 1993 as part of his Dangerous World Tour, followed by a second performance in 1996 during his HIStory World Tour. His popularity in Russia, alongside the potential participation of a Jackson family member in a prominent international event, is already generating buzz among music fans and industry insiders. While the identity of the potential performer remains unconfirmed, there is speculation that it may be one of the younger generation of Jacksons, who have already started to carve out careers in the entertainment industry. In recent years, the music industry has increasingly embraced younger artists who not only carry the torch of past icons but also bring fresh perspectives and modern sensibilities to their craft. This blend of legacy and innovation is particularly fitting for Intervision, where diverse musical expressions converge. By choosing a descendant of Michael Jackson, the U.S. could showcase how its musical heritage inspires contemporary artistry and resonates across generations. About Intervision Intervision is an international music competition that originated in the late 1970s, serving as a counterpart to Eurovision for countries in Eastern Europe, the Soviet Union, and parts of Asia. The event was initially aimed at fostering cultural exchange and showcasing musical diversity that was less influenced by Western pop trends. After a long hiatus, the competition was revived in the 21st century, now attracting global artists to participate. Social Links Telegram: https://t.me/intervision_world VK: https://vk.com/intervision.world OK: https://ok.ru/group/70000037652397 Rutube: https://rutube.ru/channel/64873781/ TikTok: https://www.tiktok.com/@intervision.world YouTube: https://www.youtube.com/@intervisionworld.official X: https://x.com/intervisionwld?s=11 Media contact Brand: Intervision’25 International Music Contest Contact: PR team Email: media@intervision.world Website: https://intervision.world/en/

Los Angeles, CA – August 10, 2025 – (SeaPRwire) – The Intervision’25 International Music Contest is set to take place in Moscow on September 20th, 2025, promising a high-profile celebration of global musical talent. In connection with the event, there is growing buzz suggesting that a descendant of Michael Jackson may be among the participants, though this remains unconfirmed. The 2025 edition is expected to offer a high-quality production with elaborate stage designs and will likely attract significant media attention. And it is expected to host artists from more than 20 countries, each presenting a musical style that reflects their culture. Choosing a representative tied to a legendary musical legacy could be a strategic move to capture the attention of global audiences. Michael Jackson’s connection to Russia is well-documented, as he performed twice in Moscow. His first visit was in 1993 as part of his Dangerous World Tour, followed by a second performance in 1996 during his HIStory World Tour. His popularity in Russia, alongside the potential participation of a Jackson family member in a prominent international event, is already generating buzz among music fans and industry insiders. While the identity of the potential performer remains unconfirmed, there is speculation that it may be one of the younger generation of Jacksons, who have already started to carve out careers in the entertainment industry. In recent years, the music industry has increasingly embraced younger artists who not only carry the torch of past icons but also bring fresh perspectives and modern sensibilities to their craft. This blend of legacy and innovation is particularly fitting for Intervision, where diverse musical expressions converge. By choosing a descendant of Michael Jackson, the U.S. could showcase how its musical heritage inspires contemporary artistry and resonates across generations. About Intervision Intervision is an international music competition that originated in the late 1970s, serving as a counterpart to Eurovision for countries in Eastern Europe, the Soviet Union, and parts of Asia. The event was initially aimed at fostering cultural exchange and showcasing musical diversity that was less influenced by Western pop trends. After a long hiatus, the competition was revived in the 21st century, now attracting global artists to participate. Social Links Telegram: https://t.me/intervision_world VK: https://vk.com/intervision.world OK: https://ok.ru/group/70000037652397 Rutube: https://rutube.ru/channel/64873781/ TikTok: https://www.tiktok.com/@intervision.world YouTube: https://www.youtube.com/@intervisionworld.official X: https://x.com/intervisionwld?s=11 Media contact Brand: Intervision’25 International Music Contest Contact: PR team Email: media@intervision.world Website: https://intervision.world/en/